-
IONS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Ionis Pharmaceuticals (IONS)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 242.08 mm | 242.08 mm | 242.08 mm | 242.08 mm | 242.08 mm | 242.08 mm |
Cash burn (monthly) | 30.84 mm | 13.10 mm | 36.94 mm | 39.60 mm | 38.71 mm | 41.75 mm |
Cash used (since last report) | 64.16 mm | 27.25 mm | 76.85 mm | 82.38 mm | 80.53 mm | 86.84 mm |
Cash remaining | 177.92 mm | 214.83 mm | 165.23 mm | 159.70 mm | 161.54 mm | 155.23 mm |
Runway (months of cash) | 5.8 | 16.4 | 4.5 | 4.0 | 4.2 | 3.7 |
13F holders | Current |
---|---|
Total holders | 355 |
Opened positions | 61 |
Closed positions | 59 |
Increased positions | 118 |
Reduced positions | 118 |
13F shares | Current |
---|---|
Total value | 4.86 tn |
Total shares | 174.06 mm |
Total puts | 789.10 k |
Total calls | 634.10 k |
Total put/call ratio | 1.2 |
Largest owners | Shares | Value |
---|---|---|
FMR | 22.69 mm | $793.22 bn |
Vanguard | 16.47 mm | $575.88 bn |
T. Rowe Price Investment Management | 14.17 mm | $495.36 mm |
BlackRock | 11.67 mm | $407.83 bn |
Capital World Investors | 11.47 mm | $400.83 bn |
Wellington Management | 8.67 mm | $303.18 bn |
BLVGF Bellevue | 7.87 mm | $275.09 bn |
BBBOF BB Biotech | 7.85 mm | $308.19 mm |
BIIB Biogen | 5.75 mm | $347.39 mm |
STT State Street | 5.43 mm | $189.71 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Feb 25 | Patrick R. O'neil | Common Stock | Sell | Dispose S | No | Yes | 32.35 | 1,207 | 39.05 k | 56,245 |
4 Feb 25 | Patrick R. O'neil | Common Stock | Sell | Dispose S | No | Yes | 31.6203 | 6,165 | 194.94 k | 57,452 |
4 Feb 25 | Brett P Monia | Common Stock | Sell | Dispose S | No | Yes | 31.6521 | 38,843 | 1.23 mm | 180,683 |
31 Jan 25 | Eric Swayze | Common Stock | Sell | Dispose S | No | No | 32.3058 | 1,367 | 44.16 k | 48,017 |
31 Jan 25 | Eugene Schneider | Common Stock | Sell | Dispose S | No | No | 32.1967 | 1,484 | 47.78 k | 61,056 |
30 Jan 25 | Eric Swayze | Common Stock | Grant | Acquire A | No | No | 0 | 3,714 | 0.00 | 49,384 |
30 Jan 25 | Eugene Schneider | Common Stock | Grant | Acquire A | No | No | 0 | 4,032 | 0.00 | 62,540 |